Bringing Trial Activities to the Participant Lessons from the RADIAL Proof-of-Concept Trial The move toward more participant-centric clinical research has taken an important step forward. At the Clinical Pharmacology & Therapeutics journal, the first papers from the RADIAL trial, the flagship study of the Trials@Home project have now been published, offering valuable insights into how clinical research […] The post Bringing Trial Activities to the Participant – Lessons from the RADIAL P...| Cambridge Cognition
Speech Biomarkers for Alzheimer’s Disease Show Promise Across Multiple Languages The search for reliable, accessible biomarkers for early detection of cognitive decline has taken an important step forward. At AAIC 2025, our team presented data demonstrating that speech and language patterns can serve as valid digital biomarkers for Mild Cognitive Impairment (MCI) and Alzheimer’s disease […] The post Speech Analysis as an Objective Biomarker in MDD Trials Speech Biomarkers for Alzheimer...| Cambridge Cognition
Closing the Gap Speech Analysis as an Objective Biomarker in MDD Trials The development of new therapies for Central Nervous System (CNS) disorders, particularly Major Depressive Disorder (MDD), is fundamentally challenged by the subjectivity and limitations of current assessment tools. Traditional measures, which often rely on patient self-reports or clinician ratings, frequently fail to capture […]| Cambridge Cognition
BrainsWay Deep TMS™ offers significant results by stimulating deeper & broader areas of the brain, effectively treating depression, OCD, & smoking addiction.| BrainsWay
